Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years
暂无分享,去创建一个
F. Rojo | S. Zazo | M. Cortón | E. Paz-Artal | C. Perales | I. Mahíllo-Fernández | J. Aguado | M. Fernández-Ruiz | I. Gadea | B. Almoguera | E. Guillén-Navarro | E. García-Vázquez | J. Martínez-Pérez | R. Laguna-Goya | Alberto Utrero-Rico | P. Mínguez | O. Carretero | J. Abellan-Perpiñan | S. Heili | M. Górgolas | A. Cabello | E. Mancebo | J. Ruiz-Hornillos | M. E. Pérez-Tomás | M. Barreda-Sánchez | L. Fernández-Caballero | E. Bernal-Morell | C. Villaverde | R. de Andrés | F. Sánchez-Martínez | R. Romero | G. Yagüe-Guirao | R. Jara-Rubio | M. Abad | A. Moreno-Docón | Cesar Calvo | Arnoldo Santos | Leticia García Rodríguez | R. Sanchez | F. Villar | M. Abián | G. P. Barba | M. Salmones | M. Muro-Amador | C. Ayuso | M. Herranz-Marín | A. Jimenez | R. López-Rodríguez | M. D. Chirlaque-López | O. Sánchez-Pernaute | L. Llanos | A. Minguela-Puras | M. Del Pozo-Valero | Andrea Martínez-Ramas | Lorena Ondo | Juan Carlos Taracido | J. A. Pons-Miñano | M. Ríos | I. J. Alfaro | Yolanda Cañadas Juárez | Antonio Herrero | J. M. Marín-Martínez | J. García-García | Juan de Dios González-Caballero | Lidia Gagliardi Alarcon | María Rubio Oliveira | Carlos Fabian Castaño Romero | Carlos Aranda Cosgaya | V. Palomares | María Torrejón | Lidia Ruth Fernández Inés García Laura Marzal Andrea Lor Fernández-Caballero Sanchez Vara Gordo Mart | Inés García Vara | Laura Marzal Gordo | M. Torrejón | Felipe Villar
[1] F. Rieux-Laucat,et al. Clonal hematopoiesis is not significantly associated with COVID-19 disease severity , 2022, Blood.
[2] P. Awadalla,et al. Clonal hematopoiesis is associated with risk of severe Covid-19 , 2021, Nature communications.
[3] S. Mustjoki,et al. Somatic Mutations in "Benign" Disease. , 2021, The New England journal of medicine.
[4] J. Zschocke,et al. Clonal hematopoiesis in patients with Covid‐19 is stable and not linked to an aggravated clinical course , 2021, American journal of hematology.
[5] A. Bick,et al. Germline risk of clonal haematopoiesis , 2021, Nature Reviews Genetics.
[6] Stuart M. Gardos,et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis , 2020, Nature Genetics.
[7] H. Moch,et al. Clonal Hematopoiesis in Hospitalized Elderly Patients With COVID-19 , 2020, HemaSphere.
[8] A. Zeiher,et al. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure. , 2020, JAMA cardiology.
[9] B. Quesnel,et al. Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19 , 2020, Cancers.
[10] V. Shivarov,et al. Clonal haematopoiesis and COVID‐19: A possible deadly liaison , 2020, International journal of immunogenetics.
[11] L. Bullinger,et al. Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis , 2020, Haematologica.
[12] L. Bullinger,et al. Clonal hematopoiesis in patients with ANCA-associated vasculitis. , 2019, Haematologica.
[13] Alexandros Kouris,et al. VarSome: the human genomic variant search engine , 2018, bioRxiv.
[14] M. Dubé,et al. DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. , 2017, Blood.
[15] Kari Stefansson,et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. , 2017, Blood.
[16] M. McCarthy,et al. Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.
[17] S. Gabriel,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.
[18] Stef van Buuren,et al. MICE: Multivariate Imputation by Chained Equations in R , 2011 .